First patient in global breast cancer trial

First patient in global breast cancer trial

The Cancer Centers of Southwest Oklahoma is the first to enroll a patient in a phase 3 clinical trial that targets breast cancer. ARV 71 is a new oral pill created by Pfizer to combat breast cancer, and the oral medication works by blocking estrogen receptors in a...